Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Proceedings: Medical adrenalectomy using aminoglutethimide and dexamethasone in advanced breast cancer.

× No keyword cloud information.

17 in total

Review 1. Recent Progress in the Discovery of Next Generation Inhibitors of Aromatase from the Structure-Function Perspective.

Authors: Debashis Ghosh; Jessica Lo; Chinaza Egbuta
Journal: J Med Chem Date: 2016-01-19 Impact factor: 7.446

Review 2. The role of aromatase inhibitors in ameliorating deleterious effects of ovarian stimulation on outcome of infertility treatment.

Authors: Mohamed F M Mitwally; Robert F Casper; Michael P Diamond
Journal: Reprod Biol Endocrinol Date: 2005-10-04 Impact factor: 5.211

Review 3. Aromatase inhibitors: past, present and future in breast cancer therapy.

Authors: Udayan Dutta; Kartikeya Pant
Journal: Med Oncol Date: 2007-11-01 Impact factor: 3.064

Review 4. Recent advances in studies on estrogen biosynthesis.

Authors: A M Brodie
Journal: J Endocrinol Invest Date: 1979 Oct-Dec Impact factor: 4.256

Review 5. Suppression of estrogens with aminoglutethimide and hydrocortisone (medical adrenalectomy) as treatment of advanced breast carcinoma: a review.

Authors: R J Santen
Journal: Breast Cancer Res Treat Date: 1981 Impact factor: 4.872

Review 6. Preservation of androgen secretion during estrogen suppression with aminoglutethimide in the treatment of metastatic breast carcinoma.

Authors: E Samojlik; J D Veldhuis; S A Wells; R J Santen
Journal: J Clin Invest Date: 1980-03 Impact factor: 14.808

7. Effects of Fadrozole (CGS 16949A) and Letrozole (CGS 20267) on the inhibition of aromatase activity in breast cancer patients.

Authors: L M Demers
Journal: Breast Cancer Res Treat Date: 1994 Impact factor: 4.872

Review 8. First generation aromatase inhibitors--aminoglutethimide and testololactone.

Authors: G Cocconi
Journal: Breast Cancer Res Treat Date: 1994 Impact factor: 4.872

9. Treatment of advanced breast cancer in postmenopausal women with 4-hydroxyandrostenedione.

Authors: R C Stein; M Dowsett; A Hedley; J Davenport; J C Gazet; H T Ford; R C Coombes
Journal: Cancer Chemother Pharmacol Date: 1990 Impact factor: 3.333

10. Medical adrenalectomy in patients with advanced breast cancer resistant to anti-oestrogen treatment.

Authors: R M Murray; P Pitt
Journal: Breast Cancer Res Treat Date: 1981 Impact factor: 4.872